← back
CVE-2024-45099

IBM Security ReaQta cross-site scripting

CVSS 3.1 LOWEPSS 0.2%CWE-79
Vexday Risk Score
8Low
SSVC decision (CISA)
Track
No exploitation signal → monitor
CVSS 3.1EPSS 0.2%KEV nãoPoC Nuclei Metasploit Patch referenciado
Lifecycle
14 Nov 2024Published on NVD
Recommendation: Monitor — no exploitation signal at the moment.
IBM Security ReaQta 3.12 is vulnerable to cross-site scripting. This vulnerability allows a privileged user to embed arbitrary JavaScript code in the Web UI thus altering the intended functionality potentially leading to credentials disclosure within a trusted session.
CVSS:3.1/AV:N/AC:H/PR:H/UI:R/S:U/C:L/I:L/A:N
Affected products
IBM · Security ReaQta